AR028470A1 - Ariltiofeno agonistas de vasopresina, el uso de los mismos para manufactura de un medicamento y composicion farmaceutica - Google Patents

Ariltiofeno agonistas de vasopresina, el uso de los mismos para manufactura de un medicamento y composicion farmaceutica

Info

Publication number
AR028470A1
AR028470A1 ARP000100462A ARP000100462A AR028470A1 AR 028470 A1 AR028470 A1 AR 028470A1 AR P000100462 A ARP000100462 A AR P000100462A AR P000100462 A ARP000100462 A AR P000100462A AR 028470 A1 AR028470 A1 AR 028470A1
Authority
AR
Argentina
Prior art keywords
manufacture
vasopresina
ariltiofeno
agasistas
composition
Prior art date
Application number
ARP000100462A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR028470A1 publication Critical patent/AR028470A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Agonistas de vasopresina, que comprende un compuesto de la formula (1), donde R1, R2, R3, R4, R5, R6, A, B, C, Y y m tienen el significado dado en la memoria descriptiva. Además describe el uso de los mismos para la manufactura de un medicamento para tratar trastornos que se solucionan o alivian por medio de estos agonistas de vasopresina seleccionados del grupo formado por diabetes insípida, enuresis nocturna, incontinencia urinaria, trastornos del sangrado y coagulacion, o retardo temporal de la orina.
ARP000100462A 1999-02-04 2000-02-03 Ariltiofeno agonistas de vasopresina, el uso de los mismos para manufactura de un medicamento y composicion farmaceutica AR028470A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24417999A 1999-02-04 1999-02-04

Publications (1)

Publication Number Publication Date
AR028470A1 true AR028470A1 (es) 2003-05-14

Family

ID=22921681

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100462A AR028470A1 (es) 1999-02-04 2000-02-03 Ariltiofeno agonistas de vasopresina, el uso de los mismos para manufactura de un medicamento y composicion farmaceutica

Country Status (7)

Country Link
EP (1) EP1149103A1 (es)
JP (1) JP2002536377A (es)
CN (1) CN1339036A (es)
AR (1) AR028470A1 (es)
AU (1) AU2603000A (es)
CA (1) CA2358891A1 (es)
WO (1) WO2000046227A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022969A2 (en) * 1999-09-27 2001-04-05 American Cynamid Company Vasopressin agonist formulation and process
BR0208823A (pt) 2001-04-12 2004-03-09 Wyeth Corp Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
US5849735A (en) * 1995-01-17 1998-12-15 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
WO2000046227A1 (en) 2000-08-10
AU2603000A (en) 2000-08-25
CN1339036A (zh) 2002-03-06
CA2358891A1 (en) 2000-08-10
EP1149103A1 (en) 2001-10-31
JP2002536377A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
BR9811585A (pt) Agonistas de vasopressinas tricìclicas
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
DK1079807T3 (da) Anvendelse af præparater til tilförsel af antiseptiske midler og/eller midler, som fremmer heling af sår, til de nedre luftveje
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
PE20060485A1 (es) Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
AR029605A1 (es) DERIVADOS DE DIFENILUREA SUBSTITUIDOS CON SULFONAMIDA , COMPOSICIoN FARMACEUTICA , USO DE LOS MISMOS PARA LA MANUFACTURA DE UN MEDICAMENTO uTILES COMO ANTAGONISTA DE RECEPTORES DE IL-8, COMPUESTOS, INTERMEDIARIOS, Y MÉTODOS DE CONVERSIoN DE COMPUESTOS
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
TR200200066T2 (tr) Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri
ECSP045025A (es) Combinación de opioides seleccionados con antagonistas muscarnicos para el tratamiento de la incontinencia urinaria
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
AR028470A1 (es) Ariltiofeno agonistas de vasopresina, el uso de los mismos para manufactura de un medicamento y composicion farmaceutica
BR0318242A (pt) derivados de azabiciclo hexano substituìdo como antagonistas de receptores muscarìnicos e processo para sua preparação
DE69826677D1 (de) Trizyclische vasopressin agoniste
DK1326592T3 (da) Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
AR020559A1 (es) Compuestos n-oxidos de piridina triciclicos, agonistas de la vasopresina, composicion farmaceutica que los comprende y el uso de los mismos para lamanufactura de un medicamento.
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
AR029361A1 (es) Compuestos de guanidina ciclicas antagonistas de los receptores de la il- 8, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento
SE0000303D0 (sv) Novel compounds
AR008083A1 (es) Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc.
BR0112957A (pt) Composto, método de tratamento, uso de um composto, e, composição farmacêutica
AR072810A1 (es) Compuesto de 3-( 4 fenilsulfonil-1-piperazinil) carbonil) pirazolo(1,5 -a) pirimidina , composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento para el tratamiento del dolor.